Frank Pasqualone Theravance Biopharma, Inc. (TBPH) insider trading activity

Frank Pasqualone is SVP, CHIEF BUSINESS OFFICER of Theravance Biopharma, Inc.. Currently has a direct ownership of 429,783 shares of TBPH, which is worth approximately $4.13 Million. The most recent transaction as insider was on Nov 19, 2021, when has been sold 3,779 shares (Ordinary Shares) at a price of $8.36 per share, resulting in proceeds of $31,592. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 430K

0% 3M change

0% 12M change

Total Value Held $4.13 Million

FRANK PASQUALONE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 19 2021	SELL Payment of exercise price or tax liability	$31,592 $8.36 p/Share	3,779 Reduced 0.87%	429,783 Ordinary Shares
Aug 20 2021	SELL Payment of exercise price or tax liability	$53,095 $14.05 p/Share	3,779 Reduced 0.86%	433,562 Ordinary Shares
May 20 2021	SELL Payment of exercise price or tax liability	$67,266 $17.8 p/Share	3,779 Reduced 0.86%	437,341 Ordinary Shares
Feb 20 2021	SELL Payment of exercise price or tax liability	$506,597 $18.79 p/Share	26,961 Reduced 5.78%	439,719 Ordinary Shares
Feb 08 2021	BUY Grant, award, or other acquisition	-	65,000 Added 12.23%	466,680 Ordinary Shares
Nov 20 2020	SELL Payment of exercise price or tax liability	$72,523 $17.21 p/Share	4,214 Reduced 1.04%	401,680 Ordinary Shares

Also insider at

ENVB

Enveric Biosciences, Inc. Healthcare